Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

MLA

Mark Stacy, et al. “Clinico-Immunologic Aspects of Botulinum Toxin Type B Treatment of Cervical Dystonia.” Neurology, vol. 67, Dec. 2006, pp. 2233–35. EBSCOhost, https://doi.org/10.1212/01.wnl.0000249308.66959.43.

APA

Mark Stacy, Kapil D. Sethi, Cynthia L. Comella, Behzod Z. Dolimbek, Allison Brashear, M. Z. Atassi, Carlos Singer, Christine Hunter, Daniel Tarsy, Charles H. Adler, Marc L. Gordon, Gulnoz S. Dolimbek, David E. Riley, & Joseph Jankovic. (2006). Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia. Neurology, 67, 2233–2235. https://doi.org/10.1212/01.wnl.0000249308.66959.43

Chicago

Mark Stacy, Kapil D. Sethi, Cynthia L. Comella, Behzod Z. Dolimbek, Allison Brashear, M. Z. Atassi, Carlos Singer, et al. 2006. “Clinico-Immunologic Aspects of Botulinum Toxin Type B Treatment of Cervical Dystonia.” Neurology 67 (December): 2233–35. doi:10.1212/01.wnl.0000249308.66959.43.